NUDT22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.331200E-01
Normal-vs-Stage2
7.231600E-01
Normal-vs-Stage3
8.270800E-01
Normal-vs-Stage4
8.361000E-01
Stage1-vs-Stage2
7.564000E-01
Stage1-vs-Stage3
7.498800E-01
Stage1-vs-Stage4
7.932200E-01
Stage2-vs-Stage3
6.449600E-01
Stage2-vs-Stage4
4.921400E-01
Stage3-vs-Stage4
9.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.194200E-01
Normal-vs-AfricanAmerican
9.762200E-01
Normal-vs-Asian
1.382180E-01
Caucasian-vs-AfricanAmerican
7.137800E-01
Caucasian-vs-Asian
6.723800E-02
AfricanAmerican-vs-Asian
1.030950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.967200E-01
Normal-vs-Female
7.699800E-01
Male-vs-Female
9.965800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.371400E-01
Normal-vs-Age(41-60Yrs)
7.395200E-01
Normal-vs-Age(61-80Yrs)
8.336800E-01
Normal-vs-Age(81-100Yrs)
3.641400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.099400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.144000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.803600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.747600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.273800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.463800E-01
Normal-vs-Daily Drinker
4.112200E-01
Normal-vs-Weekly Drinker
4.709200E-01
Normal-vs-Occasional Drinker
4.299800E-01
Normal-vs-Social Drinker
6.611400E-01
Non Drinker-vs-Daily Drinker
1.077380E-01
Non Drinker-vs-Weekly Drinker
5.360600E-01
Non Drinker-vs-Occasional Drinker
2.523000E-01
Non Drinker-vs-Social Drinker
6.282000E-01
Daily Drinker-vs-Weekly Drinker
2.387200E-01
Daily Drinker-vs-Occasional Drinker
6.141000E-01
Daily Drinker-vs-Social Drinker
3.571000E-01
Weekly Drinker-vs-Occasional Drinker
5.054800E-01
Weekly Drinker-vs-Social Drinker
9.829000E-01
Occasional Drinker-vs-Social Drinker
5.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.992200E-01
Normal-vs-Grade 2
1.627020E-01
Normal-vs-Grade 3
1.448820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.232500E-02
Grade 1-vs-Grade 3
5.990400E-02
Grade 1-vs-Grade 4
4.992200E-01
Grade 2-vs-Grade 3
9.414600E-01
Grade 2-vs-Grade 4
1.627020E-01
Grade 3-vs-Grade 4
1.448820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.362600E-01
Normal-vs-NonDiabetic
6.708800E-01
Diabetic-vs-NonDiabetic
9.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.343630E-01
Normal-vs-NoPancreatitis
8.508000E-01
Pancreatitis-vs-NoPancreatitis
3.181900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.241800E-01
Normal-vs-N1
8.328400E-01
N0-vs-N1
2.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.252800E-01
Normal-vs-TP53-NonMutant
8.770600E-01
TP53-Mutant-vs-TP53-NonMutant
1.966390E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
